Trial NCT01848652

View at ClinicalTrials.gov 
Org. Study IDs: RB 12.032 - MYLY

Last trial update was posted on 2015-07-14

MeSH Interventions

Doxorubicin

MeSH Conditions

Lymphoma Lymphoma, B-Cell

Other Conditions

Cerebral Lymphoma B Cell Refractory

Stopping Reasons

The laboratory's partner on this study decides to terminate the contract with the CHRU Brest, because of the difficulty of the recruitment.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID